E2F7 Can Regulate Proliferation, Differentiation, and Apoptotic Responses in Human Keratinocytes: Implications for Cutaneous Squamous Cell Carcinoma Formation
- 1 March 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (5) , 1800-1808
Abstract
The E2F family of transcription factors plays a crucial role in the regulation of genes involved in cell proliferation, differentiation, and apoptosis. In keratinocytes, the inhibition of E2F is a key step in the control and initiation of squamous differentiation. Because the product of the recently identified E2F7a/E2F7b gene has been shown to repress E2F-regulated promoters, and to be abundant in skin, we examined its role in the epidermis. Our results indicate that E2F7b mRNA expression is selectively associated with proliferation-competent keratinocytes. Moreover, E2F7 was able to antagonize E2F1-induced proliferation and apoptosis. In contrast, although E2F7 was able to inhibit proliferation and initiate differentiation, it was unable to antagonize the differentiation suppression induced by E2F1. These data indicate that E2F7-mediated suppression of proliferation and apoptosis acts through E2F1-dependent pathways, whereas E2F7-induced differentiation acts through an E2F1-independent pathway. These data also suggest that proliferation, differentiation, and survival of primary human keratinocytes can be controlled by the relative ratio of E2F1 to E2F7. Because deregulated proliferation, differentiation, and apoptosis are hallmarks of cancer, we examined the expression levels of E2F1 and E2F7 in cutaneous squamous cell carcinomas (CSCC). We found that both genes were overexpressed in CSCCs compared with normal epidermis. Furthermore, inhibition of E2F7 in a SCC cell line sensitized the cells to UV-induced apoptosis and doxorubicin-induced apoptosis. Combined, these data suggest that the selected disruption of E2F1 and E2F7 in keratinocytes is likely to contribute to CSCC formation and may prove to be a viable therapeutic target. [Cancer Res 2009;69(5):1800–9]Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Skin stem cells: rising to the surfaceJournal of Cell Biology, 2008
- DNA‐damage response control of E2F7 and E2F8EMBO Reports, 2008
- Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic DevelopmentDevelopmental Cell, 2008
- An E2F1-Dependent Gene Expression Program that Determines the Balance between Proliferation and Cell DeathCancer Cell, 2008
- E2F Modulates Keratinocyte Squamous DifferentiationJournal of Biological Chemistry, 2003
- Suppression of Keratinocyte Growth and Differentiation by Transforming Growth Factor β1 Involves Multiple Signaling PathwaysJournal of Investigative Dermatology, 2001
- The Hallmarks of CancerCell, 2000
- Cytochrome P450, CYP26AI, is expressed at low levels in human epidermal keratinocytes and is not retinoic acid-inducibleBritish Journal of Dermatology, 1999
- Regulation of the Transglutaminase I GeneJournal of Biological Chemistry, 1999
- Regulation of Proliferation-Specific and Differentiation-Specific Genes during Senescence of Human Epidermal Keratinocyte and Mammary Epithelial CellsBiochemical and Biophysical Research Communications, 1993